SGS data for 33 pairs of stomach adenocarcinomas (STADs) and adjacent non-malignant tissues from The Cancer Genome Atlas (TCGA) cohort also demonstrated higher expression of DGAT1 in cancers (Fig. 8c; Mann–Whitney U test, p = 0.002). This evidence concerns the gene DGAT1 and gastric adenocarcinoma.